In vitro experiments such as western blot, PCR, siRNA, cell cloning, and Transwell assay verified the role of the screened target cytochrome c oxidase 19 (COX19) in COAD, thus partially confirming the reliability of the bioinformatics analysis results. This evidence concerns the gene COX19 and colon adenocarcinoma.